Financial Ratios

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE680.85-4.2 (-0.61 %)
PREV CLOSE ( ) 685.05
OPEN PRICE ( ) 688.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5838
TODAY'S LOW / HIGH ( )679.75 698.00
52 WK LOW / HIGH ( )556.05 774.75
NSE681.50-8 (-1.16 %)
PREV CLOSE( ) 689.50
OPEN PRICE ( ) 689.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30154
TODAY'S LOW / HIGH( ) 680.20 697.80
52 WK LOW / HIGH ( )563.9 775.45
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)13.6322.9920.938.588.39
   CEPS(Rs)15.4124.2822.1910.079.50
   DPS(Rs)4.604.604.202.102.15
   Book NAV/Share(Rs)99.1290.4973.5354.5449.86
   Tax Rate(%)25.7425.8225.2927.2029.32
Margin Ratios
   Core EBITDA Margin(%)11.7319.1120.2011.7912.21
   EBIT Margin(%)14.1922.4624.7913.3113.77
   Pre Tax Margin(%)14.1322.3224.6113.1813.69
   PAT Margin (%)10.4916.5618.389.599.67
   Cash Profit Margin (%)11.8717.4919.4911.2610.96
Performance Ratios
   ROA(%)11.3221.7825.9413.0514.18
   ROE(%)14.3728.0332.6916.4417.87
   ROCE(%)19.3837.9344.0022.8025.43
   Asset Turnover(x)1.081.321.411.361.47
   Sales/Fixed Asset(x)6.269.318.507.097.44
   Working Capital/Sales(x)1.932.061.953.012.45
Efficiency Ratios
   Fixed Capital/Sales(x)0.160.110.120.140.13
   Receivable days34.2625.1524.1941.4643.86
   Inventory Days26.3619.5422.5826.7317.96
   Payable days108.19102.2693.7595.4386.35
Valuation Parameters
   PER(x)42.1934.5327.1538.4537.05
   PCE(x)37.3132.6925.6132.7632.71
   Price/Book(x)5.808.777.736.056.23
   Yield(%)0.800.580.740.640.69
   EV/Net Sales(x)4.245.504.573.553.26
   EV/Core EBITDA(x)27.2623.5117.6623.7121.68
   EV/EBIT(x)29.8924.4918.4526.6823.71
   EV/CE(x)4.506.455.624.624.51
   M Cap / Sales4.435.724.993.693.58
Growth Ratio
   Net Sales Growth(%)-6.4621.9327.293.2015.17
   Core EBITDA Growth(%)-37.7810.20120.082.655.44
   EBIT Growth(%)-40.9110.50137.11-0.274.87
   PAT Growth(%)-40.719.80143.952.3222.27
   EPS Growth(%)-40.719.80143.952.32-38.86
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)4.123.554.283.223.87
   Quick Ratio(x)3.663.213.942.613.46
   Interest Cover(x)241.99156.66139.35102.57172.19
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.